Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 163 entries
Sorted by: Best Match Show Resources per page
The long journey of salicylates in ulcerative colitis: The past and the future.

Journal of Crohn's & colitis

Caprilli R, Cesarini M, Angelucci E, Frieri G.
PMID: 21172263
J Crohns Colitis. 2009 Sep;3(3):149-56. doi: 10.1016/j.crohns.2009.05.001. Epub 2009 May 29.

The advent of salicylates in the treatment of ulcerative colitis started in 1938 with the discovery of Salazopyrin by Nanna Svartz. This drug offered for the first time a therapeutic chance to patients with ulcerative colitis. In this paper...

Cite
Caprilli R, Cesarini M, Angelucci E, et al. The long journey of salicylates in ulcerative colitis: The past and the future. J Crohns Colitis. 2009;3(3):149-56doi: 10.1016/j.crohns.2009.05.001.
Caprilli, R., Cesarini, M., Angelucci, E., & Frieri, G. (2009). The long journey of salicylates in ulcerative colitis: The past and the future. Journal of Crohn's & colitis, 3(3), 149-56. https://doi.org/10.1016/j.crohns.2009.05.001
Caprilli, Renzo, et al. "The long journey of salicylates in ulcerative colitis: The past and the future." Journal of Crohn's & colitis vol. 3,3 (2009): 149-56. doi: https://doi.org/10.1016/j.crohns.2009.05.001
Caprilli R, Cesarini M, Angelucci E, Frieri G. The long journey of salicylates in ulcerative colitis: The past and the future. J Crohns Colitis. 2009 Sep;3(3):149-56. doi: 10.1016/j.crohns.2009.05.001. Epub 2009 May 29. PMID: 21172263.
Copy Download .nbib Format: NLM
A MODEL OF THE POTASSIUM EFFECT.

The Journal of general physiology

Osterhout WJ.
PMID: 19873379
J Gen Physiol. 1943 Nov 20;27(2):91-100. doi: 10.1085/jgp.27.2.91.

The protoplasm of certain cells is able to distinguish electrically between K(+) and Na(+). This has been called the potassium effect. This is illustrated by experiments with Nitella. When 0.01 M KCl which has stood in contact with Nitella...

Cite
Osterhout WJ. A MODEL OF THE POTASSIUM EFFECT. J Gen Physiol. 1943;27(2):91-100doi: 10.1085/jgp.27.2.91.
Osterhout, W. J. (1943). A MODEL OF THE POTASSIUM EFFECT. The Journal of general physiology, 27(2), 91-100. https://doi.org/10.1085/jgp.27.2.91
Osterhout, W J. "A MODEL OF THE POTASSIUM EFFECT." The Journal of general physiology vol. 27,2 (1943): 91-100. doi: https://doi.org/10.1085/jgp.27.2.91
Osterhout WJ. A MODEL OF THE POTASSIUM EFFECT. J Gen Physiol. 1943 Nov 20;27(2):91-100. doi: 10.1085/jgp.27.2.91. PMID: 19873379; PMCID: PMC2142586.
Copy Download .nbib Format: NLM
A Clinical Lecture ON THE ACTION OF SALICYLATES IN ACUTE RHEUMATISM.

British medical journal

Stockman R.
PMID: 20762945
Br Med J. 1906 Nov 24;2(2395):1439-42. doi: 10.1136/bmj.2.2395.1439.

No abstract available.

Cite
Stockman R. A Clinical Lecture ON THE ACTION OF SALICYLATES IN ACUTE RHEUMATISM. Br Med J. 1906;2(2395):1439-42doi: 10.1136/bmj.2.2395.1439.
Stockman, R. (1906). A Clinical Lecture ON THE ACTION OF SALICYLATES IN ACUTE RHEUMATISM. British medical journal, 2(2395), 1439-42. https://doi.org/10.1136/bmj.2.2395.1439
Stockman, R. "A Clinical Lecture ON THE ACTION OF SALICYLATES IN ACUTE RHEUMATISM." British medical journal vol. 2,2395 (1906): 1439-42. doi: https://doi.org/10.1136/bmj.2.2395.1439
Stockman R. A Clinical Lecture ON THE ACTION OF SALICYLATES IN ACUTE RHEUMATISM. Br Med J. 1906 Nov 24;2(2395):1439-42. doi: 10.1136/bmj.2.2395.1439. PMID: 20762945; PMCID: PMC2382582.
Copy Download .nbib Format: NLM
Infliximab-Induced Lupus: A Case Report.

GE Portuguese journal of gastroenterology

Magno Pereira V, Andrade C, Figueira R, Faria G, Jasmins L.
PMID: 29255743
GE Port J Gastroenterol. 2017 Mar;24(2):84-88. doi: 10.1159/000450877. Epub 2016 Nov 19.

We report the case of a 48-year-old, leukodermic female diagnosed with ulcerative proctitis for 4 years and latent tuberculosis. She was allergic to salicylates and had a minor allergic reaction to infliximab (rash, vertigo, and headache). Thereafter, she started...

Cite
Magno Pereira V, Andrade C, Figueira R, et al. Infliximab-Induced Lupus: A Case Report. GE Port J Gastroenterol. 2016;24(2):84-88doi: 10.1159/000450877.
Magno Pereira, V., Andrade, C., Figueira, R., Faria, G., & Jasmins, L. (2017). Infliximab-Induced Lupus: A Case Report. GE Portuguese journal of gastroenterology, 24(2), 84-88. https://doi.org/10.1159/000450877
Magno Pereira, Vítor, et al. "Infliximab-Induced Lupus: A Case Report." GE Portuguese journal of gastroenterology vol. 24,2 (2017): 84-88. doi: https://doi.org/10.1159/000450877
Magno Pereira V, Andrade C, Figueira R, Faria G, Jasmins L. Infliximab-Induced Lupus: A Case Report. GE Port J Gastroenterol. 2017 Mar;24(2):84-88. doi: 10.1159/000450877. Epub 2016 Nov 19. PMID: 29255743; PMCID: PMC5729968.
Copy Download .nbib Format: NLM
Medical History in the Hellenic Journal of Nuclear Medicine.

Hellenic journal of nuclear medicine

Otte A.
PMID: 28426839
Hell J Nucl Med. 2017 Jan-Apr;20(1):2.

The Hellenic Journal of Nuclear Medicine is about to celebrate its 20th anniversary end of 2017. On board of the editorial team since 2003, this journal has influenced me like a good friend over the many past years. From...

Cite
Otte A. Medical History in the Hellenic Journal of Nuclear Medicine. Hell J Nucl Med. 2017;20(1):2
Otte, A. (2017). Medical History in the Hellenic Journal of Nuclear Medicine. Hellenic journal of nuclear medicine, 20(1), 2.
Otte, Andreas. "Medical History in the Hellenic Journal of Nuclear Medicine." Hellenic journal of nuclear medicine vol. 20,1 (2017): 2.
Otte A. Medical History in the Hellenic Journal of Nuclear Medicine. Hell J Nucl Med. 2017 Jan-Apr;20(1):2. PMID: 28426839.
Copy Download .nbib Format: NLM
The dimerization of .

Acta pharmaceutica Sinica. B

Cuadari A, Pollastro F, Unciti-Broceta JD, Caprioglio D, Minassi A, Lopatriello A, Muñoz E, Taglialatela-Scafati O, Appendino G.
PMID: 31649855
Acta Pharm Sin B. 2019 Sep;9(5):1078-1083. doi: 10.1016/j.apsb.2019.06.007. Epub 2019 Jun 24.

The renewed interest in dimeric salicylates as broad-spectrum anti-inflammatory and anti-diabetic agents provided a rationale to investigate the dimerization of the substituted salicylate

Cite
Cuadari A, Pollastro F, Unciti-Broceta JD, et al. The dimerization of . Acta Pharm Sin B. 2019;9(5):1078-1083doi: 10.1016/j.apsb.2019.06.007.
Cuadari, A., Pollastro, F., Unciti-Broceta, J. D., Caprioglio, D., Minassi, A., Lopatriello, A., Muñoz, E., Taglialatela-Scafati, O., & Appendino, G. (2019). The dimerization of . Acta pharmaceutica Sinica. B, 9(5), 1078-1083. https://doi.org/10.1016/j.apsb.2019.06.007
Cuadari, Arben, et al. "The dimerization of ." Acta pharmaceutica Sinica. B vol. 9,5 (2019): 1078-1083. doi: https://doi.org/10.1016/j.apsb.2019.06.007
Cuadari A, Pollastro F, Unciti-Broceta JD, Caprioglio D, Minassi A, Lopatriello A, Muñoz E, Taglialatela-Scafati O, Appendino G. The dimerization of . Acta Pharm Sin B. 2019 Sep;9(5):1078-1083. doi: 10.1016/j.apsb.2019.06.007. Epub 2019 Jun 24. PMID: 31649855; PMCID: PMC6804457.
Copy Download .nbib Format: NLM
Critical illness and multi-organ failure following topical application of skin-lightening preparation.

Anaesthesia reports

Rudge JE, Raithatha M.
PMID: 32051947
Anaesth Rep. 2019 Jun 11;7(1):47-49. doi: 10.1002/anr3.12014. eCollection 2019.

Topical application of skin-lightening cream is increasingly undertaken in many non-Caucasian populations for cultural and social reasons. It is a rare cause of poisoning that has potential to lead to significant harm due to skin damage and systemic absorption...

Cite
Rudge JE, Raithatha M. Critical illness and multi-organ failure following topical application of skin-lightening preparation. Anaesth Rep. 2019;7(1):47-49doi: 10.1002/anr3.12014.
Rudge, J. E., & Raithatha, M. (2019). Critical illness and multi-organ failure following topical application of skin-lightening preparation. Anaesthesia reports, 7(1), 47-49. https://doi.org/10.1002/anr3.12014
Rudge, J E, and Raithatha, M. "Critical illness and multi-organ failure following topical application of skin-lightening preparation." Anaesthesia reports vol. 7,1 (2019): 47-49. doi: https://doi.org/10.1002/anr3.12014
Rudge JE, Raithatha M. Critical illness and multi-organ failure following topical application of skin-lightening preparation. Anaesth Rep. 2019 Jun 11;7(1):47-49. doi: 10.1002/anr3.12014. eCollection 2019. PMID: 32051947; PMCID: PMC6931301.
Copy Download .nbib Format: NLM
Corrigendum to "A comprehensive review on the biological interest of quinoline and its derivatives" [Bioorg. Med. Chem. 32 (2021) 115973].

Bioorganic & medicinal chemistry

Matada BS, Pattanashettar R, Yernale NG.
PMID: 33740641
Bioorg Med Chem. 2021 May 01;37:116098. doi: 10.1016/j.bmc.2021.116098. Epub 2021 Mar 16.

No abstract available.

Cite
Matada BS, Pattanashettar R, Yernale NG. Corrigendum to "A comprehensive review on the biological interest of quinoline and its derivatives" [Bioorg. Med. Chem. 32 (2021) 115973]. Bioorg Med Chem. 2021;37:116098doi: 10.1016/j.bmc.2021.116098.
Matada, B. S., Pattanashettar, R., & Yernale, N. G. (2021). Corrigendum to "A comprehensive review on the biological interest of quinoline and its derivatives" [Bioorg. Med. Chem. 32 (2021) 115973]. Bioorganic & medicinal chemistry, 37116098. https://doi.org/10.1016/j.bmc.2021.116098
Matada, Basavarajaiah Suliphuldevara, et al. "Corrigendum to "A comprehensive review on the biological interest of quinoline and its derivatives" [Bioorg. Med. Chem. 32 (2021) 115973]." Bioorganic & medicinal chemistry vol. 37 (2021): 116098. doi: https://doi.org/10.1016/j.bmc.2021.116098
Matada BS, Pattanashettar R, Yernale NG. Corrigendum to "A comprehensive review on the biological interest of quinoline and its derivatives" [Bioorg. Med. Chem. 32 (2021) 115973]. Bioorg Med Chem. 2021 May 01;37:116098. doi: 10.1016/j.bmc.2021.116098. Epub 2021 Mar 16. PMID: 33740641.
Copy Download .nbib Format: NLM
A Case Report of Hypoglycemia Following a Tramadol Overdose in a Non-Diabetic Patient.

Journal of pharmacy practice

Weant KA, Clendening AM, Bush JS.
PMID: 33736525
J Pharm Pract. 2021 Mar 19;8971900211000701. doi: 10.1177/08971900211000701. Epub 2021 Mar 19.

INTRODUCTION: Tramadol is an opioid analgesic that binds to mu-opioid receptors and inhibits the uptake of norepinephrine and serotonin. Through its activation of these receptors, it has potential to increase the utilization of glucose and/or decrease hepatic gluconeogenesis.CASE REPORT:...

Cite
Weant KA, Clendening AM, Bush JS. A Case Report of Hypoglycemia Following a Tramadol Overdose in a Non-Diabetic Patient. J Pharm Pract. 2021;8971900211000701doi: 10.1177/08971900211000701.
Weant, K. A., Clendening, A. M., & Bush, J. S. (2021). A Case Report of Hypoglycemia Following a Tramadol Overdose in a Non-Diabetic Patient. Journal of pharmacy practice, 8971900211000701. https://doi.org/10.1177/08971900211000701
Weant, Kyle A, et al. "A Case Report of Hypoglycemia Following a Tramadol Overdose in a Non-Diabetic Patient." Journal of pharmacy practice vol. (2021): 8971900211000701. doi: https://doi.org/10.1177/08971900211000701
Weant KA, Clendening AM, Bush JS. A Case Report of Hypoglycemia Following a Tramadol Overdose in a Non-Diabetic Patient. J Pharm Pract. 2021 Mar 19;8971900211000701. doi: 10.1177/08971900211000701. Epub 2021 Mar 19. PMID: 33736525.
Copy Download .nbib Format: NLM
P049 Investigation of Liver Diseases by Ultrasound in Patients With Inflammatory Bowel Disease.

The American journal of gastroenterology

Shintaku D, Lopes M, de Oliveira AC, Beraldo R, Godoi G, Castelhano N, Pereira J, Vulcano D, de Oliveira EC, Herrerias G, Saad-Hossne R, Baima J, Barbosa W, Silva G, Sassaki L.
PMID: 35006176
Am J Gastroenterol. 2021 Dec 01;116:S12-S13. doi: 10.14309/01.ajg.0000798796.64423.34.

BACKGROUND: Inflammatory Bowel Disease (IBD), which can be divided into Crohn's Disease (CD) and Ulcerative Colitis (UC), is an immune mediated disease featured by gastrointestinal tract involvement. Hepatic disease, such as non-alcoholic fatty liver disease (NAFLD), cirrhosis, cholelithiasis, hepatic...

Cite
Shintaku D, Lopes M, de Oliveira AC, et al. P049 Investigation of Liver Diseases by Ultrasound in Patients With Inflammatory Bowel Disease. Am J Gastroenterol. 2021;116:S12-S13doi: 10.14309/01.ajg.0000798796.64423.34.
Shintaku, D., Lopes, M., de Oliveira, A. C., Beraldo, R., Godoi, G., Castelhano, N., Pereira, J., Vulcano, D., de Oliveira, E. C., Herrerias, G., Saad-Hossne, R., Baima, J., Barbosa, W., Silva, G., & Sassaki, L. (2021). P049 Investigation of Liver Diseases by Ultrasound in Patients With Inflammatory Bowel Disease. The American journal of gastroenterology, 116S12-S13. https://doi.org/10.14309/01.ajg.0000798796.64423.34
Shintaku, Daniel, et al. "P049 Investigation of Liver Diseases by Ultrasound in Patients With Inflammatory Bowel Disease." The American journal of gastroenterology vol. 116 (2021): S12-S13. doi: https://doi.org/10.14309/01.ajg.0000798796.64423.34
Shintaku D, Lopes M, de Oliveira AC, Beraldo R, Godoi G, Castelhano N, Pereira J, Vulcano D, de Oliveira EC, Herrerias G, Saad-Hossne R, Baima J, Barbosa W, Silva G, Sassaki L. P049 Investigation of Liver Diseases by Ultrasound in Patients With Inflammatory Bowel Disease. Am J Gastroenterol. 2021 Dec 01;116:S12-S13. doi: 10.14309/01.ajg.0000798796.64423.34. PMID: 35006176.
Copy Download .nbib Format: NLM
Vedolizumab-Induced Liver Injury.

GE Portuguese journal of gastroenterology

Mascarenhas Saraiva M, Ribeiro T, Dias E, Lopes JL, Cardoso H, Macedo G.
PMID: 34901448
GE Port J Gastroenterol. 2020 Dec 03;28(6):410-415. doi: 10.1159/000511644. eCollection 2021.

Drug-induced liver injury is an important cause of acute liver injury. Immunomodulatory therapies, such as vedolizumab (VDZ), are being increasingly used for the treatment of several diseases, most importantly inflammatory bowel disease. Several studies have demonstrated the safety of...

Cite
Mascarenhas Saraiva M, Ribeiro T, Dias E, et al. Vedolizumab-Induced Liver Injury. GE Port J Gastroenterol. 2020;28(6):410-415doi: 10.1159/000511644.
Mascarenhas Saraiva, M., Ribeiro, T., Dias, E., Lopes, J. L., Cardoso, H., & Macedo, G. (2021). Vedolizumab-Induced Liver Injury. GE Portuguese journal of gastroenterology, 28(6), 410-415. https://doi.org/10.1159/000511644
Mascarenhas Saraiva, Miguel, et al. "Vedolizumab-Induced Liver Injury." GE Portuguese journal of gastroenterology vol. 28,6 (2021): 410-415. doi: https://doi.org/10.1159/000511644
Mascarenhas Saraiva M, Ribeiro T, Dias E, Lopes JL, Cardoso H, Macedo G. Vedolizumab-Induced Liver Injury. GE Port J Gastroenterol. 2020 Dec 03;28(6):410-415. doi: 10.1159/000511644. eCollection 2021. PMID: 34901448; PMCID: PMC8630383.
Copy Download .nbib Format: NLM
Family Transmission of COVID-19 Including a Child with MIS-C and Acute Pancreatitis.

International medical case reports journal

Abbas M, Törnhage CJ.
PMID: 33574714
Int Med Case Rep J. 2021 Feb 05;14:55-65. doi: 10.2147/IMCRJ.S284480. eCollection 2021.

INTRODUCTION: Spread of the novel coronavirus SARS-CoV-2, since at least December 2019, has caused a pandemic. SARS-CoV-2 causes the disease COVID-19, which can affect several human organs. Abdominal pain is one of the known symptoms, but little is known...

Cite
Abbas M, Törnhage CJ. Family Transmission of COVID-19 Including a Child with MIS-C and Acute Pancreatitis. Int Med Case Rep J. 2021;14:55-65doi: 10.2147/IMCRJ.S284480.
Abbas, M., & Törnhage, C. J. (2021). Family Transmission of COVID-19 Including a Child with MIS-C and Acute Pancreatitis. International medical case reports journal, 1455-65. https://doi.org/10.2147/IMCRJ.S284480
Abbas, Maher, and Törnhage, Carl-Johan. "Family Transmission of COVID-19 Including a Child with MIS-C and Acute Pancreatitis." International medical case reports journal vol. 14 (2021): 55-65. doi: https://doi.org/10.2147/IMCRJ.S284480
Abbas M, Törnhage CJ. Family Transmission of COVID-19 Including a Child with MIS-C and Acute Pancreatitis. Int Med Case Rep J. 2021 Feb 05;14:55-65. doi: 10.2147/IMCRJ.S284480. eCollection 2021. PMID: 33574714; PMCID: PMC7872935.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 163 entries